ml-3000 has been researched along with Carcinoma, Intraepithelial in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biddick, L; Kopelovich, L; Li, Q; Lightfoot, S; Madka, V; Mohammed, A; Patlolla, JM; Rao, CV; Steele, V; Wu, XR; Zhang, Y | 1 |
Brewer, M; Cruz-Monserrate, Z; Houchen, CW; Janakiram, NB; Kumar, G; Lightfoot, S; Madka, V; May, R; Mohammed, A; Patlolla, JM; Rao, CV; Ritchie, RL; Sadeghi, M; Steele, VE; Yamada, HY | 1 |
2 other study(ies) available for ml-3000 and Carcinoma, Intraepithelial
Article | Year |
---|---|
Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice.
Topics: Animals; Antigens, Polyomavirus Transforming; Blotting, Western; Carcinoma in Situ; Cell Movement; Cell Proliferation; Female; Immunoenzyme Techniques; Lipoxygenase; Male; Mice; Mice, Transgenic; Neoplasm Invasiveness; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Pyrroles; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urinary Bladder Neoplasms; Uroplakin II | 2014 |
Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Arachidonic Acid; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Cell Proliferation; Ceruletide; Cyclooxygenase 2; Disease Models, Animal; Disease Progression; Doublecortin-Like Kinases; Lipoxygenase Inhibitors; Mice; Mice, Knockout; MicroRNAs; Neoplastic Stem Cells; Pancreatic Neoplasms; Pancreatitis; Protein Serine-Threonine Kinases; Pyrroles | 2015 |